drugset / Trial / NCT02588716
Effects of Terlipressin on Blood Loss and Transfusion Requirements During Major Liver Resection.
RandomizedParallel-groupDouble-blindPrevention
Summary
To evaluate the effects of Terlipressin infusion on blood loss \& transfusion requirements in cirrhotic patients undergoing major liver resections.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-03
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Terlipressin | Peptide | 2 ug/kg | Intravenous |